title: Discovery of selective alpha(2C) adrenergic receptor agonists.
authors.affiliation: UCB New Medicines, Chemin du Foriest, 1420 Braine-l'Alleud, Belgium. eric.jnoff@ucb.com
authors.forename: Eric
authors.initials: E
authors.lastname: Jnoff
authors.forename: Bernard
authors.initials: B
authors.lastname: Christophe
authors.forename: Philippe
authors.initials: P
authors.lastname: Collart
authors.forename: Francis
authors.initials: F
authors.lastname: Coloretti
authors.forename: Aurel
authors.initials: A
authors.lastname: Debeuckelaere
authors.forename: Marc
authors.initials: M
authors.lastname: De Ryck
authors.forename: Bruno
authors.initials: B
authors.lastname: Fuks
authors.forename: Christophe
authors.initials: C
authors.lastname: Genicot
authors.forename: Michel
authors.initials: M
authors.lastname: Gillard
authors.forename: Michel
authors.initials: M
authors.lastname: Guyaux
authors.forename: Nathalie
authors.initials: N
authors.lastname: Price
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Vandergeten
authors.forename: Céline
authors.initials: C
authors.lastname: Vermeiren
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000700:Analgesics / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D055808:Drug Discovery; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy* / Q000503:physiopathology; D010080:Oxazoles / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000627:therapeutic use; D010147:Pain Measurement; D051381:Rats; D018341:Receptors, Adrenergic, alpha-2 / Q000378:metabolism*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000700:Analgesics; D010080:Oxazoles; D018341:Receptors, Adrenergic, alpha-2